Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ranked No. 1 on Newsweek’s annual list of America’s Most Responsible Companies for the second year in a row.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has earned the top spot on Newsweek’s annual list of America’s Most Responsible Companies, ranking No. 1 overall for the first time
Merck was named one of America’s Most JUST Companies, making this the sixth consecutive year that Merck has been recognized for its commitment to serving its workers, customers, communities, the environment, and shareholders.
HIV remains a global epidemic. Merck has been committed to advancing science for the treatment and prevention of HIV for more than 35 years, but we know it takes more — it takes all of us to make a difference for the HIV community.
While those days were difficult, Rodrique said he was fortunate that his background in cardiovascular disease at Merck helped him to better understand his parents’ diagnoses and have informed conversations with their doctors.
To date, we have delivered 135,000 courses of molnupiravir through a supply and purchase agreement with the government and donated 100,000 courses of molnupiravir to Direct Relief, an organization providing emergency medical assistance.
In collaboration with key stakeholders, we work to ensure our science advances health care, and our products are accessible and affordable to those in...